12-31667910-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001135863.2(ETFBKMT):c.709G>A(p.Val237Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,614,166 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001135863.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETFBKMT | NM_001135863.2 | c.709G>A | p.Val237Ile | missense_variant | 4/4 | ENST00000357721.3 | NP_001129335.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ETFBKMT | ENST00000357721.3 | c.709G>A | p.Val237Ile | missense_variant | 4/4 | 1 | NM_001135863.2 | ENSP00000350353 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000894 AC: 136AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000815 AC: 205AN: 251474Hom.: 0 AF XY: 0.000883 AC XY: 120AN XY: 135914
GnomAD4 exome AF: 0.00183 AC: 2668AN: 1461884Hom.: 3 Cov.: 33 AF XY: 0.00174 AC XY: 1266AN XY: 727248
GnomAD4 genome AF: 0.000893 AC: 136AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000819 AC XY: 61AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.709G>A (p.V237I) alteration is located in exon 4 (coding exon 3) of the ETFBKMT gene. This alteration results from a G to A substitution at nucleotide position 709, causing the valine (V) at amino acid position 237 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at